{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT03019237",
      "orgStudyIdInfo": {
        "id": "2012-004193-25"
      },
      "organization": {
        "fullName": "Medical University of Vienna",
        "class": "OTHER"
      },
      "briefTitle": "Effect of Intranasal Anti-IgE Antibodies on IgE Production",
      "officialTitle": "The Effect of Intranasal Application of Anti-IgE Antibodies on IgE Production in Patients Suffering From Seasonal Allergic Rhinitis - a Pilot Study"
    },
    "statusModule": {
      "statusVerifiedDate": "2017-01",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2012-11"
      },
      "primaryCompletionDateStruct": {
        "date": "2013-05",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2013-05",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2017-01-10",
      "studyFirstSubmitQcDate": "2017-01-10",
      "studyFirstPostDateStruct": {
        "date": "2017-01-12",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2017-01-10",
      "lastUpdatePostDateStruct": {
        "date": "2017-01-12",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "PRINCIPAL_INVESTIGATOR",
        "investigatorFullName": "Verena Niederberger-Leppin",
        "investigatorTitle": "ao. Univ.-Prof. Dr.",
        "investigatorAffiliation": "Medical University of Vienna"
      },
      "leadSponsor": {
        "name": "Medical University of Vienna",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false
    },
    "descriptionModule": {
      "briefSummary": "In this study, participants will receive either intranasal anti-IgE-antibodies (n=5) or intranasal allergen (n=5) or intranasal placebo (n=5). Blood samples will be obtained before nasal administration of study drugs and 3, 5 and 8 weeks thereafter. In the serum samples, specific and total IgE levels will be assessed.",
      "detailedDescription": "The intranasal challenge study will be performed over 8 weeks outside of the birch pollen season (November to January) as a randomized, double blind and placebo-controlled study. During a screening visit, 15 individuals will be recruited according to eligibility criteria. They will be randomized into 3 groups (i.n. administration of anti-IgE antibodies, Bet v 1 or placebo). Intranasal administration will take place on three consecutive days and serum samples will be taken 3, 5, and 8 weeks (+/- 4 days) after the treatment for analysis of total and specific IgE levels"
    },
    "conditionsModule": {
      "conditions": [
        "Allergy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "BASIC_SCIENCE",
        "maskingInfo": {
          "masking": "TRIPLE",
          "whoMasked": [
            "PARTICIPANT",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 15,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "intranasal anti-IgE",
          "type": "EXPERIMENTAL",
          "description": "Anti-IgE (Xolair) will be freshly diluted in sterile 0.9% sodium chloride solution (438 μg/ml) and will be administered using a metered pump delivering 15 μl per puff to both nostrils on three consecutive days.",
          "interventionNames": [
            "Drug: anti-IgE"
          ]
        },
        {
          "label": "intranasal allergen",
          "type": "ACTIVE_COMPARATOR",
          "description": "GMP produced rBet v 1 will be freshly diluted in sterile 0.9% sodium chloride solution (50 μg/ml) and will be administered using a metered pump delivering 15 μl per puff to both nostrils on three consecutive days.",
          "interventionNames": [
            "Other: intranasal allergen"
          ]
        },
        {
          "label": "intranasal saline",
          "type": "PLACEBO_COMPARATOR",
          "description": "Sterile 0.9% sodium chloride solution will be administered using a metered pump delivering 15 μl per puff to both nostrils on three consecutive days.",
          "interventionNames": [
            "Other: intranasal saline"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "anti-IgE",
          "description": "intranasal anti-IgE",
          "armGroupLabels": [
            "intranasal anti-IgE"
          ],
          "otherNames": [
            "Omalizumab"
          ]
        },
        {
          "type": "OTHER",
          "name": "intranasal allergen",
          "description": "intranasal allergen",
          "armGroupLabels": [
            "intranasal allergen"
          ],
          "otherNames": [
            "GMP produced recombinant Bet v 1"
          ]
        },
        {
          "type": "OTHER",
          "name": "intranasal saline",
          "description": "intranasal placebo",
          "armGroupLabels": [
            "intranasal saline"
          ],
          "otherNames": [
            "sodium chloride 0.9%"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "change of allergen-specific IgE",
          "timeFrame": "8 weeks"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "changes in total IgE",
          "timeFrame": "8 weeks"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\nbirch pollen allergy\n\nExclusion Criteria:\n\nhistory of anaphylaxis autoimmune diseases treatment with corticosteroids, antihistamines, immunosuppressant drugs, beta-blockers significant medical conditions pregnancy or lactation",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "60 Years",
      "stdAges": [
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Verena Niederberger, MD",
          "affiliation": "Medical University of Vienna",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Dept. of Otorhinolaryngology, Medical University of Vienna",
          "city": "Vienna",
          "zip": "A-1090",
          "country": "Austria",
          "geoPoint": {
            "lat": 48.20849,
            "lon": 16.37208
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "UNDECIDED"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-11"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        }
      ],
      "ancestors": [
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "C026408",
          "term": "anti-IgE antibodies"
        },
        {
          "id": "D000069444",
          "term": "Omalizumab"
        },
        {
          "id": "D012965",
          "term": "Sodium Chloride"
        }
      ],
      "ancestors": [
        {
          "id": "D000888",
          "term": "Antibodies, Anti-Idiotypic"
        },
        {
          "id": "D000906",
          "term": "Antibodies"
        },
        {
          "id": "D007136",
          "term": "Immunoglobulins"
        },
        {
          "id": "D007162",
          "term": "Immunoproteins"
        },
        {
          "id": "D001798",
          "term": "Blood Proteins"
        },
        {
          "id": "D011506",
          "term": "Proteins"
        },
        {
          "id": "D000602",
          "term": "Amino Acids, Peptides, and Proteins"
        },
        {
          "id": "D061067",
          "term": "Antibodies, Monoclonal, Humanized"
        },
        {
          "id": "D000911",
          "term": "Antibodies, Monoclonal"
        },
        {
          "id": "D012712",
          "term": "Serum Globulins"
        },
        {
          "id": "D005916",
          "term": "Globulins"
        },
        {
          "id": "D002712",
          "term": "Chlorides"
        },
        {
          "id": "D006851",
          "term": "Hydrochloric Acid"
        },
        {
          "id": "D017606",
          "term": "Chlorine Compounds"
        },
        {
          "id": "D007287",
          "term": "Inorganic Chemicals"
        },
        {
          "id": "D017670",
          "term": "Sodium Compounds"
        }
      ]
    }
  },
  "hasResults": false
}